A new federal policy took effect on Jan. 1 that requires hospitals to post standard prices online. However, the rule, which intends to boost transparency, may be causing more confusion than clarity for patients, according to reports.

From 2006 to 2015, insurance providers kept $9.1 billion more in taxpayer funds than they would have if their estimated cost forecasts for drug spending through Medicare had been more accurate. This eye-popping statistic comes courtesy of an in-depth report published Jan. 4 by the Wall-Street Journal.

The healthcare industry took the lead as the largest employer in the United States in 2018, with high rates of job growth continuing through the end of the year, according to recent data from the Bureau of Labor Statistics.

Health insurers have been inflating cost estimates for providing prescription-drug benefits to more than 40 million Medicare beneficiaries, allowing them to cash in $9.1 billion in extra payments from 2006 to 2015, according to a report from The Wall Street Journal.

Radiology practices who hope to achieve success in CMS pay-for-performance programs should consider group participation rather than each radiologist participating as an individual, according to new research published in the Journal of the American College of Radiology.

A federal judge has intervened in the planned payment cuts to the 340B drug pricing program that enables outpatient facilities to purchase certain drugs at a lower cost.

Several Democratic states have filed notice to appeal the recent court ruling that declared the Affordable Care Act unconstitutional, The Hill reported.

The Affordable Care Act will remain in place after a judge declared the healthcare rule was unconstitutional in late December. The judge, U.S. District Court Judge Reed O'Connor, has since stated the ACA will remain in effect while the case goes through an appeals process.